GlaxoSmithKline is a step closer to curbing malaria after having developed RTS,S/AS01. Vaccine protects for up to 18 months, hopes to be ready by next year.
GlaxoSmithKline is a step closer to curbing malaria after having developed RTS,S/AS01. Vaccine protects for up to 18 months, hopes to be ready by next year.